about
Common misconceptions about data analysis and statisticsMitochondrial fission - a drug target for cytoprotection or cytodestruction?Anti-inflammatory, antiapoptotic, and antioxidant activity of fluoxetinePreclinical animal anxiety research - flaws and prejudices.Mechanisms of the gabapentinoids and α 2 δ-1 calcium channel subunit in neuropathic painPreclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonistRole of endoplasmic reticulum stress in drug-induced toxicityPharmacological implications of the Ca(2+)/cAMP signaling interaction: from risk for antihypertensive therapy to potential beneficial for neurological and psychiatric disordersPharmacology and physiology of gastrointestinal enteroendocrine cellsComparison of [(11)C]TZ1964B and [(18)F]MNI659 for PET imaging brain PDE10A in nonhuman primatesPDE10A inhibitors stimulate or suppress motor behavior dependent on the relative activation state of the direct and indirect striatal output pathwaysA pharmacokinetic evaluation and metabolite identification of the GHB receptor antagonist NCS-382 in mouse informs novel therapeutic strategies for the treatment of GHB intoxicationFibrinogen α-chain-derived peptide is upregulated in hippocampus of rats exposed to acute morphine injection and spontaneous alternation testing.Discrepancies in listed adverse drug reactions in pharmaceutical product information supplied by the regulatory authorities in Denmark and the USAClearance of rapid adenosine release is regulated by nucleoside transporters and metabolism.Safety assessment in rats and dogs of Acoustic Cluster Therapy, a novel concept for ultrasound mediated, targeted drug delivery.Preclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813.In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative.XG-102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double-blind, placebo-controlled, dose-escalating study.Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses.Key role of publication of clinical data for target validation.Interrogating the relationship between rat in vivo tissue distribution and drug property data for >200 structurally unrelated molecules.Risk of QT prolongation and torsade de pointes associated with exposure to hydroxyzine: re-evaluation of an established drug.Perivascular adipose tissue contains functional catecholamines.Magnitude and predictors of antiretroviral treatment failure among HIV-infected children in Fiche and Kuyu hospitals, Oromia region, Ethiopia: a retrospective cohort study.Structure-specific effects of lipidated oxytocin analogs on intracellular calcium levels, parental behavior, and oxytocin concentrations in the plasma and cerebrospinal fluid in mice.Acute cocaine exposure elicits rises in calcium in arousal-related laterodorsal tegmental neuronsChronic diazepam administration increases the expression of Lcn2 in the CNS.Novel SGLT2 inhibitor: first-in-man studies of antisense compound is associated with unexpected renal effects.Genome-wide DNA methylation profiling of CpG islands in a morpholino anthracycline derivative-resistant leukemia cell line: p38α as a novel candidate for resistance.Mechanical and vasomotor properties of piglet isolated middle cerebral arteryBotulinum Neurotoxins Serotypes A and B induce paralysis of mouse striated and smooth muscles with different potencies.Effects of resveratrol on drug- and carcinogen-metabolizing enzymes, implications for cancer prevention.Absorption, distribution, metabolism, and excretion of [14C]-dasotraline in humans.Medication errors involving anticoagulants: Data from the Danish patient safety databaseA three-parameter two-state model of receptor function that incorporates affinity, efficacy, and signal amplification.Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk.Exemestane potency is unchanged by common nonsynonymous polymorphisms in CYP19A1: results of a novel anti-aromatase activity assay examining exemestane and its derivatives.In vitro metabolism of exemestane by hepatic cytochrome P450s: impact of nonsynonymous polymorphisms on formation of the active metabolite 17β-dihydroexemestaneAnalgesic and anti-inflammatory properties of novel, selective, and potent EP4 receptor antagonists.
P1433
Q24289523-69541F38-D6AC-4134-9654-C4CBA5CF96CFQ26738961-718B8F0D-DEB2-4DEC-8D4C-7B2F2EB3D1E0Q26738965-4CC9B4D5-17EA-4D20-8CF7-3EE085F91079Q26749038-316ACC20-EE3D-4B74-80EE-F6DEF7DD90E8Q26749043-7228342C-D137-45C6-94DA-E40AF5935224Q26750021-4C87CD7C-3B2D-4163-95CF-A98C5C5CD6EEQ26765518-CA8375FE-8949-4F2C-A2BE-64C6004EFEFBQ26777845-7E274E25-FD09-4B1D-8E57-703A0656F2C7Q26799380-513662A2-46D5-4D7A-A4C1-F6187C054465Q28390557-058E146E-17D2-4755-B305-884C93285B3AQ28395353-B0EBF77B-5766-4C68-9F46-6335827DEC84Q28821080-D5F6FA77-665F-433A-8771-F31B9DB2EB10Q29347027-30F7177E-5A9F-4D43-8A68-85485B8898C9Q30002427-1f6935a0-491e-c767-3990-d3fe35c03319Q30277080-AC43CABA-29D6-479D-AFD4-4116A597B3F7Q30365651-AA504CEC-22D7-4AE7-9F8B-EC70186D4DAAQ30418647-A6794ECA-3E5F-44B3-A106-3041AF4EB30EQ30418651-3E980D05-C7A0-45F4-B062-0A22BE9F007FQ30423728-C13B361A-DB0B-4F81-B77D-1B5E6458009CQ30964404-EBE9AC62-056A-4837-8D24-FA4CDF9F0F86Q30984622-90BA7D56-45E3-4975-BE49-740DF3F6B916Q31013338-B0378798-6107-4988-B259-A7FC5B3A5335Q33635283-99E3F818-EBDB-4C12-8418-73D628CBACF9Q33697815-18DE29BE-08AF-4A8B-9D5D-9D90A0AFA0B5Q33771383-DB729617-3589-4604-9EE9-A7B7077C400BQ33771389-61368E52-36F9-403A-948B-21D88B36ECA5Q33771394-09155B0C-FAE8-4CC9-886D-BCF17AE6FC79Q33771399-5795EFCE-FDD7-450E-B680-ECB8E0556E4CQ33771405-5CFF88FA-9430-469C-ABAC-07A664F37B8AQ33771409-C53712EE-3B37-4025-93D9-82AA5133A2EBQ33771416-EB0FE7A1-DACC-4693-AAF0-359E253E78C2Q33771420-70C5E0AE-35C7-4549-B9B8-BB5CD157909FQ33771427-41281403-5599-41E0-83D0-CC87679F55B7Q33771433-8F054310-C183-4E15-A388-98C484D96BCBQ33777936-A6E0F0FC-3BCB-4604-BC83-5D6DD4F97312Q33777942-BF6FF833-49E8-4FC7-A097-9F357F13E76DQ33777950-6A11760A-793F-46C1-B932-8D38AB439342Q33777957-77496AB6-4315-4E64-B713-0390E56CE76AQ33777963-A8AA2EDC-251D-46B1-A6CB-A828B15BF314Q33777968-615597DF-D579-4CFF-8053-994BB32041BB
P1433
description
revista científica
@es
rivista scientifica
@it
scientific journal
@en
wetenschappelijk tijdschrift van Wiley-Blackwell
@nl
wissenschaftliche Fachzeitschrift
@de
науковий журнал
@uk
name
Pharmacology research & perspectives
@ast
Pharmacology research & perspectives
@en
Pharmacology research & perspectives
@es
Pharmacology research & perspectives
@nl
type
label
Pharmacology research & perspectives
@ast
Pharmacology research & perspectives
@en
Pharmacology research & perspectives
@es
Pharmacology research & perspectives
@nl
altLabel
Pharmacol Res Perspect
@en
Pharmacology Research & Perspectives
@en
prefLabel
Pharmacology research & perspectives
@ast
Pharmacology research & perspectives
@en
Pharmacology research & perspectives
@es
Pharmacology research & perspectives
@nl
P31
P3181
P1055
P1156
21100825823
P1277
P1476
Pharmacology research & perspectives
@en